MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm13061670

Медицинская библиотека · Journal of clinical medicine · 2024

Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Malnutrition, Frailty, Sarcopenia, or Cachexia.

Horiuchi Yu, Asami Masahiko, Yahagi Kazuyuki, Oshima Asahi, Gonda Yuki, Yoshiura Daiki, Komiyama Kota, Yuzawa Hitomi, Tanaka Jun, Aoki Jiro, Tanabe Kengo

СтатьяПеревод в очереди

Аннотация

(1)

Background

In patients with heart failure (HF) and impaired nutritional status or decreased muscle mass, sodium-glucose cotransporter-2 inhibitors (SGLT2is) may worsen these conditions and result in poor prognosis, especially worsening of frailty. We aimed to investigate the relationship between SGLT2is and clinical outcomes, including frailty-related events, in patients with HF and malnutrition, frailty, sarcopenia, or cachexia. (2)

Methods

In this retrospective observational cohort study, a global federated health research network provided data on patients with HF and malnutrition, frailty, sarcopenia, or cachexia from January 2016 to December 2021. We investigated the incidence of the composite endpoint of death or frailty-related events within one year. (3)

Results

Among 214,778 patients included in the analysis, 4715 were treated with SGLT2is. After propensity score matching, 4697 patients in the SGLT2is group were matched with 4697 patients in the non-SGLT2is groups. The incidence of the composite endpoint, mortality, and frailty-related events was lower in the SGLT2is group than in the non-SGLT2is group (composite endpoint, 65.6% versus 77.6%, p < 0.001; mortality, 17.4% vs. 35.5%, p < 0.001; frailty-related events, 59.4% vs. 64.3%, p < 0.001). (4)

Conclusions

Patients with HF and malnutrition, frailty, sarcopenia, or cachexia had a high incidence of death and frailty-related events. SGLT2is were associated with a lower incidence of these events.

Для цитирования: Horiuchi Yu, Asami Masahiko, Yahagi Kazuyuki, Oshima Asahi, Gonda Yuki, Yoshiura Daiki, Komiyama Kota, Yuzawa Hitomi, Tanaka Jun, Aoki Jiro, Tanabe Kengo. Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Malnutrition, Frailty, Sarcopenia, or Cachexia.. Journal of clinical medicine. 2024. DOI: 10.3390/jcm13061670.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.